2024 MSA Research Symposium

Event Notes:

Early Stages of MSA: Advancing Diagnostics, Biomarkers, and Interventions

Mark your calendars for the 9th of February 2024 as we invite you to join us at our eagerly awaited second MSA Symposium! Following the success of our inaugural symposium last January, we are thrilled to announce an exceptional line-up of speakers, including the esteemed Sir John Hardy OBE, Professor Claudio Soto, Professor Kailash Bhatia and Dr Wendy Philips, among others.

Join us at 33 Queens Square, UCL Institute of Neurology as these speakers provide invaluable updates on this year’s central theme: identifying the prodromal stage of MSA. This will encompass critical topics such as advancing early diagnosis, exploring biomarkers, and discussing innovative interventions.

Furthermore, we are delighted to present the latest insights into MSA drug trials, shedding light on promising developments as we strengthen our understanding and approach towards combating MSA.

For professionals seeking Continuing Professional Development (CPD) points, these will be awarded at the conclusion of the event.

Whether you are an established professional or an early career researcher, this symposium offers a unique platform to exchange knowledge and provide ample opportunities for networking where ideas can be shared and potential research collaborations can be explored. Doctors looking to enhance their expertise in diagnosing and managing Multiple System Atrophy (MSA) are warmly invited to participate. The sessions will delve into diverse aspects of MSA diagnosis and management in this year’s symposium, with a focus on early stages. Specialists in neurology, urology, autonomic, respiratory, and sleep medicine, engaged in MSA patient care, are encouraged to join.

Don’t miss this opportunity to be part of an enriching and informative event as we make strides in the fight against MSA.